| R&D SYSTEMS 产品目录--泽浩公司 |
| R&D SYSTEMS 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 413-ML-025 |
Recombinant Mouse IL-13 (25 UG) |
25 UG |
R&D SYSTEMS |
| 413-ML-025/CF |
Recombinant Mouse IL-13, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4140-ME-050 |
Recombinant Canine HGF R/c-MET/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 414-CS-005 |
Recombinant Mouse G-CSF (5 UG) |
5 UG |
R&D SYSTEMS |
| 414-CS-005/CF |
Recombinant Mouse G-CSF, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 414-CS-025 |
Recombinant Mouse G-CSF (25 UG) |
25 UG |
R&D SYSTEMS |
| 414-CS-025/CF |
Recombinant Mouse G-CSF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4150-PP-050 |
Recombinant Human Active PP2C alpha/PPM1A, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 415-ML-010 |
Recombinant Mouse GM-CSF (10 UG) |
10 UG |
R&D SYSTEMS |
| 415-ML-010/CF |
Recombinant Mouse GM-CSF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 415-ML-050 |
Recombinant Mouse GM-CSF (50 UG) |
50 UG |
R&D SYSTEMS |
| 415-ML-050/CF |
Recombinant Mouse GM-CSF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 416-ML-010/CF |
Recombinant Mouse M-CSF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 416-ML-050/CF |
Recombinant Mouse M-CSF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 417-ML-005 |
Recombinant Mouse IL-10 (5 UG) |
5 UG |
R&D SYSTEMS |
| 417-ML-005/CF |
Recombinant Mouse IL-10, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 417-ML-025 |
Recombinant Mouse IL-10 (25 UG) |
25 UG |
R&D SYSTEMS |
| 417-ML-025/CF |
Recombinant Mouse IL-10, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 418-ML-005 |
Recombinant Mouse IL-11 (5 UG) |
5 UG |
R&D SYSTEMS |
| 418-ML-005/CF |
Recombinant Mouse IL-11, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 418-ML-025 |
Recombinant Mouse IL-11 (25 UG) |
25 UG |
R&D SYSTEMS |
| 418-ML-025/CF |
Recombinant Mouse IL-11, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 419-ML-010 |
Recombinant Mouse IL-12 (10 UG) |
10 UG |
R&D SYSTEMS |
| 419-ML-010/CF |
Recombinant Mouse IL-12, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 419-ML-050 |
Recombinant Mouse IL-12 (50 UG) |
50 UG |
R&D SYSTEMS |
| 419-ML-050/CF |
Recombinant Mouse IL-12, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4206-B7-100 |
Recombinant Mouse B7-H4/Fc Chimera, CF |
100 µg |
R&D SYSTEMS |
| 4207-DM-025 |
Recombinant Human DMC/VCC-1 |
25 µg |
R&D SYSTEMS |
| 4207-DM-025 |
Recombinant Human DMC/VCC-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 4207-DM-025/CF |
Recombinant Human DMC/VCC-1, CF |
25 µg |
R&D SYSTEMS |
| 4207-DM-025/CF |
Recombinant Human DMC/VCC-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4208-NX-050 |
Recombinant Rat Neurexophilin 1/NXPH1, CF |
50 µg |
R&D SYSTEMS |
| 4208-NX-050 |
Recombinant Rat neurexophilin 1/NXPH1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4209-FC-050 |
Recombinant Human Ficolin-1, CF |
50 µg |
R&D SYSTEMS |
| 420-ME-020 |
Recombinant Mouse CCL11/Eotaxin (20 UG) |
20 UG |
R&D SYSTEMS |
| 420-ME-020/CF |
Recombinant Mouse CCL11/Eotaxin, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 420-ME-100 |
Recombinant Mouse CCL11/Eotaxin (100 UG) |
100 UG |
R&D SYSTEMS |
| 420-ME-100/CF |
Recombinant Mouse CCL11/Eotaxin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4218-UT-050 |
Recombinant Human Uteroglobin, CF |
50 µg |
R&D SYSTEMS |
| 421-ML-025 |
Recombinant Mouse IL-17 (25 UG) |
25 UG |
R&D SYSTEMS |
| 421-ML-025/CF |
Recombinant Mouse IL-17, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4234-ZN-010 |
Recombinant Human PSMA/FOLH1, CF |
10 µg |
R&D SYSTEMS |
| 4234-ZN-010 |
Recombinant Human PSMA/FOLH1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4237-SR-050 |
Recombinant Mouse SorCS2, CF |
50 µg |
R&D SYSTEMS |
| 423-F8-025 |
Recombinant Mouse FGF-8b (25 UG) |
25 UG |
R&D SYSTEMS |
| 423-F8-025/CF |
Recombinant Mouse FGF-8b, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4245-AD-020 |
Recombinant Human ADAMTS13, CF |
20 µg |
R&D SYSTEMS |
| 424-FC-025 |
Recombinant Mouse FGF-8c (25 UG) |
25 UG |
R&D SYSTEMS |
| 424-FC-025/CF |
Recombinant Mouse FGF-8c, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 425-R1-050 |
Recombinant Mouse sTNF RI/TNFRSF1A (50 UG) |
50 UG |
R&D SYSTEMS |
| 425-R1-050/CF |
Recombinant Mouse Soluble TNF RI/TNFRSF1A, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 426-R2-050 |
Recombinant Mouse sTNF RII/TNFRSF1B (50 UG) |
50 UG |
R&D SYSTEMS |
| 426-R2-050/CF |
Recombinant Mouse Soluble TNF RII/TNFRSF1B, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4270-DM-025 |
Recombinant Mouse DMC/VCC-1 |
25 µg |
R&D SYSTEMS |
| 4270-DM-025 |
Recombinant Mouse DMC/VCC-1 |
25 µg |
R&D SYSTEMS |
| 4270-DM-025/CF |
Recombinant Mouse DMC/VCC-1, CF |
25 µg |
R&D SYSTEMS |
| 4270-DM-025/CF |
Recombinant Mouse DMC/VCC-1, CF |
25 µg |
R&D SYSTEMS |
| 427-FL-005/CF |
Recombinant Mouse Flt-3 Ligand, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 427-FL-025/CF |
Recombinant Mouse Flt-3 Ligand, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4289-EG-025 |
Recombinant Human Pro-EGF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4289-EG-025 |
Recombinant Human Pro-EGF (aa 21-1023) |
25 µg |
R&D SYSTEMS |
| 4289-EG-025/CF |
Recombinant Human Pro-EGF (aa 21-1023), CF |
25 µg |
R&D SYSTEMS |
| 4289-EG-025/CF |
Recombinant Human Pro-EGF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 428-P5-025 |
Recombinant Mouse CCL12/MCP-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 428-P5-025/CF |
Recombinant Mouse CCL12/MCP-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4290-S4-050 |
Recombinant Human IGSF4D, CF |
50 µg |
R&D SYSTEMS |
| 4294-MR-050 |
Recombinant Mouse IL-22 R, CF |
50 µg |
R&D SYSTEMS |
| 4294-MR-050 |
Recombinant Mouse IL-22 R, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4295-KR-025 |
Recombinant Rat Kremen-2, CF |
25 µg |
R&D SYSTEMS |
| 4296-LR-050 |
Recombinant Human LRPAP, CF |
50 µg |
R&D SYSTEMS |
| 4296-LR-050 |
Recombinant Human LRPap, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4297-MG-050 |
Recombinant Mouse MGL1, CF |
50 µg |
R&D SYSTEMS |
| 4297-MG-050 |
Recombinant Mouse MGL1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4298-NP-050 |
Recombinant Mouse Nephronectin, CF |
50 µg |
R&D SYSTEMS |
| 429-FR-100 |
Recombinant Mouse GFR alpha-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4306-MS-010 |
Recombinant Human MSP (Cys 672 Ala) |
10 µg |
R&D SYSTEMS |
| 4306-MS-010 |
Recombinant Human MSP (Cys 672 Ala) (10 UG) |
10 UG |
R&D SYSTEMS |
| 4306-MS-010/CF |
Recombinant Human MSP (Cys 672 Ala), CF |
10 µg |
R&D SYSTEMS |
| 4306-MS-010/CF |
Recombinant Human MSP (Cys 672 Ala), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4307-AD-020 |
Recombinant Human ADAMTS4, CF |
20 µg |
R&D SYSTEMS |
| 4308-SE-010 |
Recombinant Human Prolyl Oligopeptidase/PREP, CF |
10 µg |
R&D SYSTEMS |
| 430-RI-050 |
Recombinant Mouse TNF RI/TNFRSF1A/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 430-RI-050/CF |
Recombinant Mouse TNF RI/TNFRSF1A/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4318-PR-050 |
Recombinant Mouse PILR-alpha, CF |
50 µg |
R&D SYSTEMS |
| 431-MS-100 |
Recombinant Mouse MSP R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4325-FC-050 |
Recombinant Human Fc gamma RIIIA/CD16a, CF |
50 µg |
R&D SYSTEMS |
| 4326-RG-050 |
Recombinant Rat IGF-I, CF |
50 µg |
R&D SYSTEMS |
| 4327-SA-050 |
Recombinant Human S100A13, CF |
50 µg |
R&D SYSTEMS |
| 4328-SA-050 |
Recombinant Mouse S100A13, CF |
50 µg |
R&D SYSTEMS |
| 4329-EG-025 |
Recombinant Mouse EGFL6, CF |
25 µg |
R&D SYSTEMS |
| 432-B3-200 |
Recombinant Mouse EphB3/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 433-MC-025 |
Recombinant Mouse LIX (25 UG) |
25 UG |
R&D SYSTEMS |
| 433-MC-025/CF |
Recombinant Mouse LIX, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 434-CT-200 |
Recombinant Mouse CTLA-4/Fc Chimera (200 UG) |
200 UG |
R&D SYSTEMS |
| 434-CT-200/CF |
Recombinant Mouse CTLA-4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 4359-DA-050 |
Recombinant Human Histone Deacetylase 8, CF |
50 µg |
R&D SYSTEMS |
| 435-FA-050 |
Recombinant Mouse Fas/TNFRSF6/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 435-FA-050/CF |
Recombinant Mouse Fas (CD95)/TNFRSF6/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4376-TG-050 |
Recombinant Human Transglutaminase 2/TGM2, CF |
50 µg |
R&D SYSTEMS |
| 437-MR-100 |
Recombinant Mouse BMPR-IA/ALK-3/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 437-MR-100/CF |
Recombinant Mouse BMPR-IA/ALK-3/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4384-CD-050 |
Recombinant Human CDO, CF |
50 µg |
R&D SYSTEMS |
| 4385-CD-050 |
Recombinant Human CD109, CF |
50 µg |
R&D SYSTEMS |
| 4386-DM-050 |
Recombinant Mouse DMP-1, CF |
50 µg |
R&D SYSTEMS |
| 4387-ER-050 |
Recombinant Mouse ErbB4/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 4387-ER-050 |
Recombinant Mouse ErbB4/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 4388-MR-050 |
Recombinant Mouse IL-20 R beta/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 4389-OR-050 |
Recombinant Human OSM R beta/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 438-CT-010 |
Recombinant Mouse Cardiotrophin-1 (CT-1) (10 UG) |
10 UG |
R&D SYSTEMS |
| 438-CT-010/CF |
Recombinant Mouse Cardiotrophin-1 (CT-1), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 438-CT-050 |
Recombinant Mouse Cardiotrophin-1 (CT-1) (50 UG) |
50 UG |
R&D SYSTEMS |
| 438-CT-050/CF |
Recombinant Mouse Cardiotrophin-1 (CT-1), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4394-AS-050 |
Recombinant Human ASGPR1, CF |
50 µg |
R&D SYSTEMS |
| 4394-AS-050 |
Recombinant Human ASGPR1, CF |
50 µg |
R&D SYSTEMS |
| 4395-SR-050 |
Recombinant Mouse SorCS1, CF |
50 µg |
R&D SYSTEMS |
| 4395-SR-050 |
Recombinant Mouse SorCS1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4397-EN-010 |
Recombinant Human CD39/ENTPD1, CF |
10 µg |
R&D SYSTEMS |
| 4397-EN-010 |
Recombinant Human CD39/ENTPD1, CF |
10 µg |
R&D SYSTEMS |
| 4398-EN-010 |
Recombinant Mouse CD39/ENTPD1, CF |
10 µg |
R&D SYSTEMS |
| 4398-EN-010 |
Recombinant Mouse CD39/ENTPD1, CF |
10 µg |
R&D SYSTEMS |
| 4399-EN-010 |
Recombinant Human CD39L2/ENTPD6, CF |
10 µg |
R&D SYSTEMS |
| 439-MD-025 |
Recombinant Mouse CCL22/MDC (25 UG) |
25 UG |
R&D SYSTEMS |
| 439-MD-025/CF |
Recombinant Mouse CCL22/MDC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4400-EN-010 |
Recombinant Human CD39L3/ENTPD3, CF |
10 µg |
R&D SYSTEMS |
| 440-M3-025 |
Recombinant Mouse CCL19/MIP-3 beta (25 UG) |
25 UG |
R&D SYSTEMS |
| 440-M3-025/CF |
Recombinant Mouse CCL19/MIP-3 beta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4415-SU-010 |
Recombinant Human Arylsulfatase B/ARSB, CF |
10 µg |
R&D SYSTEMS |
| 4416-AD-020 |
Recombinant Human ADAM12, CF |
20 µg |
R&D SYSTEMS |
| 441-OP-050 |
Recombinant Mouse Osteopontin (OPN) (50 UG) |
50 UG |
R&D SYSTEMS |
| 441-OP-050/CF |
Recombinant Mouse Osteopontin (OPN), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 441-OP-200 |
Recombinant Mouse Osteopontin (OPN) (200 UG) |
200 UG |
R&D SYSTEMS |
| 441-OP-200/CF |
Recombinant Mouse Osteopontin (OPN), CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 442-LK-002 |
Recombinant Mouse CXCL15/Lungkine (2 UG) |
2 UG |
R&D SYSTEMS |
| 4434-CK-025 |
Recombinant Rat CCL27/CTACK |
25 µg |
R&D SYSTEMS |
| 4434-CK-025/CF |
Recombinant Rat CCL27/CTACK, CF |
25 µg |
R&D SYSTEMS |
| 4435-BD-050 |
Recombinant Human beta-Defensin 3, CF |
50 µg |
R&D SYSTEMS |
| 4436-DN-050 |
Recombinant Mouse DNAM-1/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 4437-IL-025 |
Recombinant Rat IL-17F |
25 µg |
R&D SYSTEMS |
| 4437-IL-025 |
Recombinant Rat IL-17F |
25 µg |
R&D SYSTEMS |
| 4437-IL-025/CF |
Recombinant Rat IL-17F, CF |
25 µg |
R&D SYSTEMS |
| 4437-IL-025/CF |
Recombinant Rat IL-17F, CF |
25 µg |
R&D SYSTEMS |
| 443-KD-050 |
Recombinant Mouse VEGF R2/Flk-1/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 443-KD-050/CF |
Recombinant Mouse VEGF R2/Flk-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4444-TR-050 |
Recombinant Human Thrombopoietin R, CF |
50 µg |
R&D SYSTEMS |
| 444-BNS-100 |
Recombinant Mouse BMPR-IB/ALK-6/Fc Chimera (NSO) (100 UG) |
100 UG |
R&D SYSTEMS |
| 444-BNS-100/CF |
Recombinant Mouse BMPR-IB/ALK-6/Fc Chimera (NSO), CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4460-MG-100 |
Recombinant Mouse IgG2A Fc, CF |
100 µg |
R&D SYSTEMS |
| 446-B4-200 |
Recombinant Mouse EphB4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 447-ML-010 |
Recombinant Mouse IL-15 (10 UG) |
10 UG |
R&D SYSTEMS |
| 447-ML-010/CF |
Recombinant Mouse IL-15, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4480-LR-050 |
Recombinant Mouse LRPAP, CF |
50 µg |
R&D SYSTEMS |
| 4481-MR-100 |
Recombinant Mouse IL-17 R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4484-N2-050 |
Recombinant Human Neuregulin-2/NRG2, CF |
50 µg |
R&D SYSTEMS |
| 4485-NX-050 |
Recombinant Rat Neurexin 1 alpha/NRXN1a, CF |
50 µg |
R&D SYSTEMS |
| 4486-SB-050 |
Recombinant Human SIRP gamma/CD172g/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 4487-AN-050 |
Recombinant Human Angiopoietin-like 4, CF |
50 µg |
R&D SYSTEMS |
| 4488-EN-010 |
Recombinant Mouse 5'-Nucleotidase/CD73, CF |
10 µg |
R&D SYSTEMS |
| 4490-HP-050 |
Recombinant Human Hemopexin, CF |
50 µg |
R&D SYSTEMS |
| 4494-AH-010 |
Recombinant Human ASAHL, CF |
10 µg |
R&D SYSTEMS |
| 450-MA-010 |
Recombinant Mouse CCL3/MIP-1 alpha (10 UG) |
10 UG |
R&D SYSTEMS |
| 450-MA-010/CF |
Recombinant Mouse CCL3/MIP-1 alpha, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 450-MA-050 |
Recombinant Mouse CCL3/MIP-1 alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 450-MA-050/CF |
Recombinant Mouse CCL3/MIP-1 alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4516-ZN-010 |
Recombinant Rat ACE-2, CF |
10 µg |
R&D SYSTEMS |
| 4517-SE-010 |
Recombinant Mouse Neutrophil Elastase/ELA2, CF |
10 µg |
R&D SYSTEMS |
| 4518-RB-050 |
Recombinant Mouse ErbB3/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 451-MB-010 |
Recombinant Mouse CCL4/MIP-1 beta (10 UG) |
10 UG |
R&D SYSTEMS |
| 451-MB-010/CF |
Recombinant Mouse CCL4/MIP-1 beta, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 451-MB-050 |
Recombinant Mouse CCL4/MIP-1 beta (50 UG) |
50 UG |
R&D SYSTEMS |
| 451-MB-050/CF |
Recombinant Mouse CCL4/MIP-1 beta, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4520-GP-050 |
Recombinant Mouse Glypican 1, CF |
50 µg |
R&D SYSTEMS |
| 4529-HB-050 |
Recombinant Mouse HABP1/C1QBP, CF |
50 µg |
R&D SYSTEMS |
| 452-M2-010 |
Recombinant Mouse MIP-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 452-M2-010/CF |
Recombinant Mouse MIP-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 452-M2-050 |
Recombinant Mouse MIP-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 452-M2-050/CF |
Recombinant Mouse MIP-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 453-KC-010 |
Recombinant Mouse KC (10 UG) |
10 UG |
R&D SYSTEMS |
| 453-KC-010/CF |
Recombinant Mouse KC, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 453-KC-050 |
Recombinant Mouse KC (50 UG) |
50 UG |
R&D SYSTEMS |
| 453-KC-050/CF |
Recombinant Mouse KC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4540-KS-010 |
Recombinant Human Active Raf-1 (Y340E Y341E, 306-end), CF |
10 µg |
R&D SYSTEMS |
| 4544-NS-050 |
Recombinant Human INSL3, CF |
50 µg |
R&D SYSTEMS |
| 4546-SA-050 |
Recombinant Human SIRP alpha/CD172a, CF |
50 µg |
R&D SYSTEMS |
| 454-A8-200 |
Recombinant Mouse EphA8/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 4556-SE-010 |
Recombinant Mouse Coagulation Factor XI, CF |
10 µg |
R&D SYSTEMS |
| 4557-PI-010 |
Recombinant Mouse Cystatin F, CF |
10 µg |
R&D SYSTEMS |
| 455-MC-010 |
Recombinant Mouse SCF (10 UG) |
10 UG |
R&D SYSTEMS |
| 455-MC-010/CF |
Recombinant Mouse SCF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 455-MC-050 |
Recombinant Mouse SCF (50 UG) |
50 UG |
R&D SYSTEMS |
| 455-MC-050/CF |
Recombinant Mouse SCF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 456-MC-010 |
Recombinant Mouse CCL7/MARC (10 UG) |
10 UG |
R&D SYSTEMS |
| 456-MC-010/CF |
Recombinant Mouse CCL7/MARC, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 456-MC-050 |
Recombinant Mouse CCL7/MARC (50 UG) |
50 UG |
R&D SYSTEMS |
| 456-MC-050/CF |
Recombinant Mouse CCL7/MARC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 457-6C-025 |
Recombinant Mouse CCL21/6Ckine (25 UG) |
25 UG |
R&D SYSTEMS |
| 457-6C-025/CF |
Recombinant Mouse CCL21/6Ckine, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 458-MF-025 |
Recombinant Mouse CX3CL1/Fractalkine (Chemokine Domain) (25 UG) |
25 UG |
R&D SYSTEMS |
| 458-MF-025/CF |
Recombinant Mouse CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 459-MO-100 |
Recombinant Mouse Osteoprotegerin/TNFRSF11B/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4600-SU-010 |
Recombinant Mouse Arylsulfatase G/ARSG, CF |
10 µg |
R&D SYSTEMS |
| 4604-TG-050 |
Recombinant Human Transglutaminase 3/TGM3, CF |
50 µg |
R&D SYSTEMS |
| 460-SD-010 |
Recombinant Mouse CXCL12/SDF-1 alpha (10 UG) |
10 UG |
R&D SYSTEMS |
| 460-SD-010/CF |
Recombinant Mouse CXCL12/SDF-1 alpha, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 460-SD-050 |
Recombinant Mouse CXCL12/SDF-1 alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 460-SD-050/CF |
Recombinant Mouse CXCL12/SDF-1 alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4610-TH-010 |
Recombinant Human TSH alpha/beta |
10 µg |
R&D SYSTEMS |
| 461-SH-025 |
Recombinant Mouse Sonic Hedgehog, N-Terminus (Shh-N) (25 UG) |
25 UG |
R&D SYSTEMS |
| 461-SH-025/CF |
Recombinant Mouse Sonic Hedgehog, N-Terminus (Shh-N), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4628-SF-050 |
Recombinant Mouse CRACC/SLAMF7, CF |
50 µg |
R&D SYSTEMS |
| 4629-DP-050 |
Recombinant Human Dermatopontin, CF |
50 µg |
R&D SYSTEMS |
| 462-TEC-010 |
Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli-expressed) (10 UG) |
10 UG |
R&D SYSTEMS |
| 462-TEC-010/CF |
Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 462-TR-010 |
Recombinant Mouse TRANCE/RANK L/TNFSF11 (10 UG) |
10 UG |
R&D SYSTEMS |
| 462-TR-010/CF |
Recombinant Mouse TRANCE/RANK L/TNFSF11, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4630-DC-050 |
Recombinant Human Desmocollin-3, CF |
50 µg |
R&D SYSTEMS |
| 4635-ML-025 |
Recombinant Mouse IL-28A/IFN-lambda 2 |
25 µg |
R&D SYSTEMS |
| 4635-ML-025/CF |
Recombinant Mouse IL-28A/IFN-lambda 2, CF |
25 µg |
R&D SYSTEMS |
| 4636-NL-050 |
Recombinant Mouse Noelin-1, CF |
50 µg |
R&D SYSTEMS |
| 463-MG-025 |
Recombinant Mouse CCL9/10/MIP-1 gamma (25 UG) |
25 UG |
R&D SYSTEMS |
| 463-MG-025/CF |
Recombinant Mouse CCL9/10/MIP-1 gamma, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4644-VS-010 |
Recombinant Human VEGF 121 (aa 207-327) |
10 µg |
R&D SYSTEMS |
| 4644-VS-010/CF |
Recombinant Human VEGF 121 (aa 207-327) |
10 µg |
R&D SYSTEMS |
| 464-SH-025 |
Recombinant Mouse Sonic Hedgehog (C25II) N-Terminus (25 UG) |
25 UG |
R&D SYSTEMS |
| 464-SH-025/CF |
Recombinant Mouse Sonic Hedgehog (C25II) N-Terminus, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 465-PL-010 |
Recombinant Mouse PlGF-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 465-PL-010/CF |
Recombinant Mouse PlGF-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 465-PL-050 |
Recombinant Mouse PlGF-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 465-PL-050/CF |
Recombinant Mouse PlGF-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 466-CR-010 |
Recombinant Mouse CXCL10/IP-10/CRG-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 466-CR-010/CF |
Recombinant Mouse CXCL10/IP-10/CRG-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 466-CR-050 |
Recombinant Mouse CXCL10/IP-10/CRG-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 466-CR-050/CF |
Recombinant Mouse CXCL10/IP-10/CRG-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 467-B2-200 |
Recombinant Mouse EphB2/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 4687-CL-050 |
Recombinant Mouse CL-K1/COLEC11, CF |
50 µg |
R&D SYSTEMS |
| 468-MG-100 |
Recombinant Mouse gp130/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 4694-S4-050 |
Recombinant Human Semaphorin 4A/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 469-VD-025 |
Recombinant Mouse VEGF-D (25 UG) |
25 UG |
R&D SYSTEMS |
| 469-VD-025/CF |
Recombinant Mouse VEGF-D, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 470-BC-025 |
Recombinant Mouse CXCL13/BLC/BCA-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 470-BC-025/CF |
Recombinant Mouse CXCL13/BLC/BCA-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4710-AC-050 |
Recombinant Mouse CD157, CF |
50 µg |
R&D SYSTEMS |
| 4714-ZN-020 |
Recombinant Human Methionine Aminopeptidase 1D, CF |
20 µg |
R&D SYSTEMS |
| 471-F1-100 |
Recombinant Mouse VEGF R1/Flt-1/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 472-FF-025 |
Recombinant Mouse CX3CL1/Fractalkine (Full Length) (25 UG) |
25 UG |
R&D SYSTEMS |
| 472-FF-025/CF |
Recombinant Mouse CX3CL1/Fractalkine (Full Length), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4736-AC-050 |
Recombinant Human CD157, CF |
50 µg |
R&D SYSTEMS |
| 473-EB-200 |
Recombinant Mouse Ephrin-B1/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 4749-MR-050 |
Recombinant Human MIS RII/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 474-MR-025 |
Recombinant Mouse IL-10 sR alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 474-MR-025/CF |
Recombinant Mouse IL-10 sR alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4750-RG-050 |
Recombinant Canine RAGE, CF |
50 µg |
R&D SYSTEMS |
| 4754-SR-050 |
Recombinant Mouse SCARA5, CF |
50 µg |
R&D SYSTEMS |
| 4778-CR-010 |
Recombinant Variola CRMB |
10 µg |
R&D SYSTEMS |
| 4778-CR-010/CF |
Recombinant Variola CRMB, CF |
10 µg |
R&D SYSTEMS |
| 477-MN-025 |
Recombinant Mouse Neurturin (25 UG) |
25 UG |
R&D SYSTEMS |
| 477-MN-025/CF |
Recombinant Mouse Neurturin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 478-MR-025 |
Recombinant Mouse CCL5/RANTES (25 UG) |
25 UG |
R&D SYSTEMS |
| 478-MR-025/CF |
Recombinant Mouse CCL5/RANTES, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 479-JE-010 |
Recombinant Mouse CCL2/JE/MCP-1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 479-JE-010/CF |
Recombinant Mouse CCL2/JE/MCP-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 479-JE-050 |
Recombinant Mouse CCL2/JE/MCP-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 479-JE-050/CF |
Recombinant Mouse CCL2/JE/MCP-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 480-RM-010 |
Recombinant Mouse IL-1ra/IL-1F3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 480-RM-010/CF |
Recombinant Mouse IL-1ra/IL-1F3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 480-RM-050 |
Recombinant Mouse IL-1ra/IL-1F3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 480-RM-050/CF |
Recombinant Mouse IL-1ra/IL-1F3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 481-TK-025 |
Recombinant Mouse CCL25/TECK (25 UG) |
25 UG |
R&D SYSTEMS |
| 481-TK-025/CF |
Recombinant Mouse CCL25/TECK, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 482-RT-100 |
Recombinant Mouse Ret/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 482-RT-100/CF |
Recombinant Mouse Ret/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 483-CD-200 |
Recombinant Mouse CD28/Fc Chimera (200 UG) |
200 UG |
R&D SYSTEMS |
| 483-CD-200/CF |
Recombinant Mouse CD28/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 485-MI-100/CF |
Recombinant Mouse IFN-gamma, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 486-LT-025 |
Recombinant Mouse XCL1/Lymphotactin (25 UG) |
25 UG |
R&D SYSTEMS |
| 486-LT-025/CF |
Recombinant Mouse XCL1/Lymphotactin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 487-C-010 |
Recombinant Mouse CCL6/C10 (10 UG) |
10 UG |
R&D SYSTEMS |
| 487-C-010/CF |
Recombinant Mouse CCL6/C10, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 487-C-050 |
Recombinant Mouse CCL6/C10 (50 UG) |
50 UG |
R&D SYSTEMS |
| 487-C-050/CF |
Recombinant Mouse CCL6/C10, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 488-TO-005 |
Recombinant Mouse Thrombopoietin (5 UG) |
5 UG |
R&D SYSTEMS |
| 488-TO-005/CF |
Recombinant Mouse Thrombopoietin, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 488-TO-025 |
Recombinant Mouse Thrombopoietin (25 UG) |
25 UG |
R&D SYSTEMS |
| 488-TO-025/CF |
Recombinant Mouse Thrombopoietin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4891-025-K |
TACS XTT Cell Proliferation/Viability Assay |
2500 Tests |
R&D SYSTEMS |
| 4891-025-K |
TACS XTT Cell Proliferation/Viability Assay |
2500 Tests |
R&D SYSTEMS |
| 4892-010-K |
Calcein AM Cell Viability Assay |
1000 Tests |
R&D SYSTEMS |
| 4892-010-K |
Calcein AM Cell Viability Assay |
1000 Tests |
R&D SYSTEMS |
| 490-IR-200 |
Recombinant Mouse IL-11 Ra/Fc Chimera (200 UG) |
200 UG |
R&D SYSTEMS |
| 490-IR-200/CF |
Recombinant Mouse IL-11 Ra/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 491-IR-200 |
Recombinant Mouse IL-13 R alpha 1/Fc Chimera (200 UG) |
200 UG |
R&D SYSTEMS |
| 491-IR-200/CF |
Recombinant Mouse IL-13 R alpha 1/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 492-MM-010 |
Recombinant Mouse CXCL9/MIG (10 UG) |
10 UG |
R&D SYSTEMS |
| 492-MM-010/CF |
Recombinant Mouse CXCL9/MIG, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 492-MM-050 |
Recombinant Mouse CXCL9/MIG (50 UG) |
50 UG |
R&D SYSTEMS |
| 492-MM-050/CF |
Recombinant Mouse CXCL9/MIG, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 493-MV-005 |
Recombinant Mouse VEGF 164 (5 UG) |
5 UG |
R&D SYSTEMS |
| 493-MV-005/CF |
Recombinant Mouse VEGF 164, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 493-MV-025 |
Recombinant Mouse VEGF 164 (25 UG) |
25 UG |
R&D SYSTEMS |
| 493-MV-025/CF |
Recombinant Mouse VEGF 164, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 494-VE-005 |
Recombinant Mouse VEGF 120 (5 UG) |
5 UG |
R&D SYSTEMS |
| 494-VE-005/CF |
Recombinant Mouse VEGF 120, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 494-VE-025 |
Recombinant Mouse VEGF 120 (25 UG) |
25 UG |
R&D SYSTEMS |
| 494-VE-025/CF |
Recombinant Mouse VEGF 120, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 495-MO-025 |
Recombinant Mouse Oncostatin M (OSM) (25 UG) |
25 UG |
R&D SYSTEMS |
| 495-MO-025/CF |
Recombinant Mouse Oncostatin M (OSM), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 496-EB-200 |
Recombinant Mouse Ephrin-B2/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 497-LR-100 |
Recombinant Mouse Leptin R/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 497-LR-100/CF |
Recombinant Mouse Leptin R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 498-OB-01M |
Recombinant Mouse Leptin, CF (1 MG) |
1 MG |
R&D SYSTEMS |
| 498-OB-05M |
Recombinant Mouse Leptin, CF (5 MG) |
5 MG |
R&D SYSTEMS |
| 499-ML-025 |
Recombinant Mouse IL-12/IL-23 p40 Homodimer (25 UG) |
25 UG |
R&D SYSTEMS |
| 499-ML-025/CF |
Recombinant Mouse IL-12/IL-23 p40 Homodimer, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 5-001-A |
Normal Sheep IgG Control (1 MG) |
1 MG |
R&D SYSTEMS |
| 500-RL-005 |
Recombinant Rat IL-1 alpha/IL-1F1 (5 UG) |
5 UG |
R&D SYSTEMS |
| 500-RL-005/CF |
Recombinant Rat IL-1 alpha/IL-1F1, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 500-RL-025 |
Recombinant Rat IL-1 alpha/IL-1F1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 500-RL-025/CF |
Recombinant Rat IL-1 alpha/IL-1F1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 501-RL-010 |
Recombinant Rat IL-1 beta/IL-1F2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 501-RL-010/CF |
Recombinant Rat IL-1 beta/IL-1F2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 501-RL-050 |
Recombinant Rat IL-1 beta/IL-1F2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 501-RL-050/CF |
Recombinant Rat IL-1 beta/IL-1F2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 502-RL-010 |
Recombinant Rat IL-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 502-RL-010/CF |
Recombinant Rat IL-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 502-RL-050 |
Recombinant Rat IL-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 502-RL-050/CF |
Recombinant Rat IL-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 503-CX-025 |
Recombinant Mouse CXCL16 (25 UG) |
25 UG |
R&D SYSTEMS |
| 503-CX-025/CF |
Recombinant Mouse CXCL16, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 504-RL-005 |
Recombinant Rat IL-4 (5 UG) |
5 UG |
R&D SYSTEMS |
| 504-RL-005/CF |
Recombinant Rat IL-4, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 504-RL-025 |
Recombinant Rat IL-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 504-RL-025/CF |
Recombinant Rat IL-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 505-PR-100 |
Recombinant Human BMPR-IB/ALK-6/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 506-RL-010 |
Recombinant Rat IL-6 (10 UG) |
10 UG |
R&D SYSTEMS |
| 506-RL-010/CF |
Recombinant Rat IL-6, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 506-RL-050 |
Recombinant Rat IL-6 (50 UG) |
50 UG |
R&D SYSTEMS |
| 506-RL-050/CF |
Recombinant Rat IL-6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 507-BP-020 |
Recombinant Human BMP-6 (20 UG) |
20 UG |
R&D SYSTEMS |
| 507-BP-020/CF |
Recombinant Human BMP-6, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 508-CK-025 |
Recombinant Human CCL23/Ck beta 8-1 (aa 46-137) (25 UG) |
25 UG |
R&D SYSTEMS |
| 508-CK-025/CF |
Recombinant Human CCL23/Ck beta 8-1 (aa 46-137), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 509-MI-025 |
Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta (25 UG) |
25 UG |
R&D SYSTEMS |
| 509-MI-025/CF |
Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 510-RT-010 |
Recombinant Rat TNF-alpha/TNFSF1A (10 UG) |
10 UG |
R&D SYSTEMS |
| 510-RT-010/CF |
Recombinant Rat TNF-alpha/TNFSF2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 510-RT-050 |
Recombinant Rat TNF-alpha/TNFSF1A (50 UG) |
50 UG |
R&D SYSTEMS |
| 510-RT-050/CF |
Recombinant Rat TNF-alpha/TNFSF2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 511-MM-010 |
Recombinant Human MMP-13, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 512-GF-010 |
Recombinant Rat GDNF (10 UG) |
10 UG |
R&D SYSTEMS |
| 512-GF-010/CF |
Recombinant Rat GDNF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 512-GF-050 |
Recombinant Rat GDNF (50 UG) |
50 UG |
R&D SYSTEMS |
| 512-GF-050/CF |
Recombinant Rat GDNF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 513-MP-010 |
Recombinant Human MMP-3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 514-CD-050 |
Recombinant Human sCD4 (50 UG) |
50 UG |
R&D SYSTEMS |
| 514-CD-050/CF |
Recombinant Human sCD4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 515-CN-010 |
Recombinant Rat CINC-1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 515-CN-010/CF |
Recombinant Rat CINC-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 515-CN-050 |
Recombinant Rat CINC-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 515-CN-050/CF |
Recombinant Rat CINC-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 516-CA-025 |
Recombinant Rat CINC-2 alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 516-CA-025/CF |
Recombinant Rat CINC-2 alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 517-CB-025 |
Recombinant Rat CINC-2 beta (25 UG) |
25 UG |
R&D SYSTEMS |
| 517-CB-025/CF |
Recombinant Rat CINC-2 beta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 518-GM-005 |
Recombinant Rat GM-CSF (5 UG) |
5 UG |
R&D SYSTEMS |
| 518-GM-005/CF |
Recombinant Rat GM-CSF, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 518-GM-025 |
Recombinant Rat GM-CSF (25 UG) |
25 UG |
R&D SYSTEMS |
| 518-GM-025/CF |
Recombinant Rat GM-CSF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 520-BB-050 |
Recombinant Rat PDGF-BB (50 UG) |
50 UG |
R&D SYSTEMS |
| 520-BB-050/CF |
Recombinant Rat PDGF-BB, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 521-RL-025 |
Recombinant Rat IL-18/IL-1F4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 521-RL-025/CF |
Recombinant Rat IL-18/IL-1F4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 522-RL-005 |
Recombinant Rat IL-10 (5 UG) |
5 UG |
R&D SYSTEMS |
| 522-RL-005/CF |
Recombinant Rat IL-10, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 522-RL-025 |
Recombinant Rat IL-10 (25 UG) |
25 UG |
R&D SYSTEMS |
| 522-RL-025/CF |
Recombinant Rat IL-10, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 523-ST-100 |
Recombinant Human IL-1 R4/ST2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 524-GR-050 |
Recombinant Mouse GITR/TNFRSF18/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 525-C3-025 |
Recombinant Rat CINC-3 (25 UG) |
25 UG |
R&D SYSTEMS |
| 525-C3-025/CF |
Recombinant Rat CINC-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 526-SA-050 |
Recombinant Mouse Fas Ligand/TNFSF6 (50 UG) |
50 UG |
R&D SYSTEMS |
| 526-SA-050/CF |
Recombinant Mouse Fas Ligand/TNFSF6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 527-ME-100 |
Recombinant Mouse HGF R/c-MET/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 528-MP-025 |
Recombinant Mouse CCL24/Eotaxin-2/MPIF-2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 528-MP-025/CF |
Recombinant Mouse CCL24/Eotaxin-2/MPIF-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 529-TR-025 |
Recombinant Mouse CCL17/TARC (25 UG) |
25 UG |
R&D SYSTEMS |
| 529-TR-025/CF |
Recombinant Mouse CCL17/TARC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 530-MR-100 |
Recombinant Mouse IL-4 R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 531-PA-100 |
Recombinant Mouse uPAR/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 532-R2-050 |
Recombinant Mouse TGF-beta RII(human)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 533-VI-025 |
Recombinant Mouse CCL28 (25 UG) |
25 UG |
R&D SYSTEMS |
| 533-VI-025/CF |
Recombinant Mouse CCL28, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 535-IN-025 |
Recombinant Porcine CXCL8/IL-8 (25 UG) |
25 UG |
R&D SYSTEMS |
| 535-IN-025/CF |
Recombinant Porcine CXCL8/IL-8, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 536-FR-025 |
Recombinant Rat CX3CL1/Fractalkine (25 UG) |
25 UG |
R&D SYSTEMS |
| 536-FR-025/CF |
Recombinant Rat CX3CL1/Fractalkine, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 537-FT-025 |
Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain) (25 UG) |
25 UG |
R&D SYSTEMS |
| 537-FT-025/CF |
Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 539-IR-100 |
Recombinant Mouse IL-13 R alpha 2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 540-RM-025 |
Recombinant Rat CCL20/MIP-3 alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 540-RM-025/CF |
Recombinant Rat CCL20/MIP-3 alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 541-A5-200 |
Recombinant Rat EphA5/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 543-RL-025 |
Recombinant Rat LIX (25 UG) |
25 UG |
R&D SYSTEMS |
| 543-RL-025/CF |
Recombinant Rat LIX, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 545-RL-010 |
Recombinant Rat IL-5 (10 UG) |
10 UG |
R&D SYSTEMS |
| 545-RL-010/CF |
Recombinant Rat IL-5, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 546-TR-050 |
Recombinant Mouse TSLP R/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 547-RL-010 |
Recombinant Rat IL-10 (Cys 167 Tyr) (10 UG) |
10 UG |
R&D SYSTEMS |
| 547-RL-010/CF |
Recombinant Rat IL-10 (Cys 167 Tyr), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 548-MM-010 |
Recombinant Mouse MMP-3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 549-R3-100 |
Recombinant Mouse IL-3 R beta/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 550-AG-100 |
Recombinant Rat Agrin (100 UG) |
100 UG |
R&D SYSTEMS |
| 550-AG-100/CF |
Recombinant Rat Agrin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 551-MR-100 |
Recombinant Mouse IL-15 R alpha/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 552-R1-010 |
Recombinant Cotton Rat IL-1 alpha/IL-1F1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 552-R1-010/CF |
Recombinant Cotton Rat IL-1 alpha/IL-1F1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 555-TS-010 |
Recombinant Mouse TSLP (10 UG) |
10 UG |
R&D SYSTEMS |
| 555-TS-010/CF |
Recombinant Mouse TSLP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 556-NG-100 |
Recombinant Rat beta-NGF (100 UG) |
100 UG |
R&D SYSTEMS |
| 556-NG-100/CF |
Recombinant Rat beta-NGF, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 557-NT-010 |
Recombinant Rat CNTF (10 UG) |
10 UG |
R&D SYSTEMS |
| 557-NT-010/CF |
Recombinant Rat CNTF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 557-NT-050 |
Recombinant Rat CNTF (50 UG) |
50 UG |
R&D SYSTEMS |
| 557-NT-050/CF |
Recombinant Rat CNTF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 558-CR-050 |
Recombinant Rat CNTF sR alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 558-CR-050/CF |
Recombinant Rat CNTF sR alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 560-GR-100/CF |
Recombinant Rat GFR alpha-1/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 561-R6-025 |
Recombinant Cotton Rat IL-6 (25 UG) |
25 UG |
R&D SYSTEMS |
| 561-R6-025/CF |
Recombinant Cotton Rat IL-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 563-MR-100 |
Recombinant Mouse IL-1 RII/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 564-RV-010 |
Recombinant Rat VEGF 164 (10 UG) |
10 UG |
R&D SYSTEMS |
| 564-RV-010/CF |
Recombinant Rat VEGF 164, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 564-RV-050 |
Recombinant Rat VEGF 164 (50 UG) |
50 UG |
R&D SYSTEMS |
| 564-RV-050/CF |
Recombinant Rat VEGF 164, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 565-RG-025 |
Recombinant Cotton Rat IFN-gamma (25 UG) |
25 UG |
R&D SYSTEMS |
| 565-RG-025/CF |
Recombinant Cotton Rat IFN-gamma, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 566-N1-025 |
Recombinant Rat Neuropilin-1/Fc Chimera, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 566-NNS-025 |
Recombinant Rat Neuropilin-1/Fc Chimera (NSO-expressed), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 567-N2-025 |
Recombinant Rat Neuropilin-2/Fc Chimera, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 568-FR-025 |
Recombinant Rat CX3CL1/Fractalkine (aa 22100) (25 UG) |
25 UG |
R&D SYSTEMS |
| 568-FR-025/CF |
Recombinant Rat CX3CL1/Fractalkine (aa 22100), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 569-A4-200 |
Recombinant Mouse Ephrin-A4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 571-MF-025 |
Recombinant Mouse CX3CL1/Fractalkine (aa 25-105) (25 UG) |
25 UG |
R&D SYSTEMS |
| 571-MF-025/CF |
Recombinant Mouse CX3CL1/Fractalkine (aa 25-105), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 572-MC-025 |
Recombinant Mouse CXCL11/I-TAC (25 UG) |
25 UG |
R&D SYSTEMS |
| 572-MC-025/CF |
Recombinant Mouse CXCL11/I-TAC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 573-RP-100 |
Recombinant Rat IL-1 R6/IL-1 R rp2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 574-CD-050 |
Recombinant Mouse CD27/TNFRSF7/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 575-ES-100 |
Recombinant Mouse E-Selectin (CD62E)/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 576-LS-100 |
Recombinant Mouse L-Selectin/CD62L/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 577-A7-100 |
Recombinant Rat ALK-7/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 578-B5-025 |
Recombinant Mouse IGFBP-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 579-R2-020 |
Recombinant Cotton Rat IL-2 (20 UG) |
20 UG |
R&D SYSTEMS |
| 579-R2-020/CF |
Recombinant Cotton Rat IL-2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 580-RT-010 |
Recombinant Rat TIMP-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 581-CR-010 |
Recombinant Cotton Rat IL-10 (Cys 149 Tyr) (10 UG) |
10 UG |
R&D SYSTEMS |
| 581-CR-010/CF |
Recombinant Cotton Rat IL-10 (Tyr), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 582-ML-010 |
Recombinant Mouse IL-22 (10 UG) |
10 UG |
R&D SYSTEMS |
| 582-ML-010/CF |
Recombinant Mouse IL-22, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 583-IC-050 |
Recombinant Rat ICAM-1/CD54/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 584-R4-010 |
Recombinant Cotton Rat IL-4 (10 UG) |
10 UG |
R&D SYSTEMS |
| 584-R4-010/CF |
Recombinant Cotton Rat IL-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 585-IF-100 |
Recombinant Rat IFN-gamma (100 UG) |
100 UG |
R&D SYSTEMS |
| 585-IF-100/CF |
Recombinant Rat IFN-gamma, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 587-RI-050 |
Recombinant Mouse TGF-beta RI/ALK-5/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 588-PL-025 |
Recombinant Porcine IL-18/IL-1F4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 588-PL-025/CF |
Recombinant Porcine IL-18/IL-1F4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 591-MR-100 |
Recombinant Mouse Mer/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 592-FR-010 |
Recombinant Mouse sFRP-3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 592-FR-010/CF |
Recombinant Mouse sFRP-3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 593-BC-050 |
Recombinant Mouse BCMA/TNFRSF17/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 594-ML-010 |
Recombinant Mouse IL-21 (10 UG) |
10 UG |
R&D SYSTEMS |
| 594-ML-010/CF |
Recombinant Mouse IL-21, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 595-P4-025 |
Recombinant Mouse CXCL4/PF4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 596-MR-100 |
Recombinant Mouse IL-21 R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 597-LM-010 |
Recombinant Mouse Limitin/Fc Chimera, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 598-LP-01M |
Recombinant Rat Leptin, CF (1 MG) |
1 MG |
R&D SYSTEMS |
| 598-LP-05M |
Recombinant Rat Leptin, CF (5 MG) |
5 MG |
R&D SYSTEMS |
| 599-JG-100 |
Recombinant Rat Jagged 1/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 6-001-A |
Normal Rat IgG Control (1 MG) |
1 MG |
R&D SYSTEMS |
| 600-VA-025 |
Recombinant Viral MIP-I (25 UG) |
25 UG |
R&D SYSTEMS |
| 600-VA-025/CF |
Recombinant Viral MIP-I, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 601-VB-025 |
Recombinant Viral MIP-II (25 UG) |
25 UG |
R&D SYSTEMS |
| 601-VB-025/CF |
Recombinant Viral MIP-II, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 602-A1-200 |
Recombinant Mouse Ephrin-A1/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 603-A2-200 |
Recombinant Mouse Ephrin-A2/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 604-4R-050 |
Recombinant Human IL-4 R/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 607-A6-200 |
Recombinant Mouse EphA6/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 608-A7-200 |
Recombinant Mouse EphA7/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 611-B6-200 |
Recombinant Mouse EphB6/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 612-CD-010 |
Recombinant Human Cardiotrophin-1 (CT-1) (10 UG) |
10 UG |
R&D SYSTEMS |
| 612-CD-010/CF |
Recombinant Human Cardiotrophin-1 (CT-1), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 612-CD-050 |
Recombinant Human Cardiotrophin-1 (CT-1) (50 UG) |
50 UG |
R&D SYSTEMS |
| 612-CD-050/CF |
Recombinant Human Cardiotrophin-1 (CT-1), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 613-FR-100 |
Recombinant Human GFR alpha-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 614-INS-100 |
Recombinant Human IL-13 R alpha 2/Fc Chimera, (NSO), CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 614-IR-100 |
Recombinant Human IL-13 R alpha 2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 615-BM-050 |
Recombinant Human BMP-5 (50 UG) |
50 UG |
R&D SYSTEMS |
| 615-BM-050/CF |
Recombinant Human BMP-5, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 617-CL-050 |
Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261) (50 UG) |
50 UG |
R&D SYSTEMS |
| 617-CL-050/CF |
Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 618-IL-010 |
Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived) (10 UG) |
10 UG |
R&D SYSTEMS |
| 618-IL-010/CF |
Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 618-IL-050 |
Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived) (50 UG) |
50 UG |
R&D SYSTEMS |
| 618-IL-050/CF |
Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 619-TI-100 |
Recombinant Human Tie-1/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 620-CM-025 |
Recombinant Viral CMV UL146/vCXC1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 620-CM-025/CF |
Recombinant Viral CMV UL146/vCXC1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 622-VD-005 |
Recombinant Human VEGF-D (5 UG) |
5 UG |
R&D SYSTEMS |
| 622-VD-005/CF |
Recombinant Human VEGF-D, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 622-VD-025 |
Recombinant Human VEGF-D (25 UG) |
25 UG |
R&D SYSTEMS |
| 622-VD-025/CF |
Recombinant Human VEGF-D, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 623-AN-025 |
Recombinant Human Angiopoietin-2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 623-AN-025/CF |
Recombinant Human Angiopoietin-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 627-CD-100 |
Recombinant Human CD6/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 628-LK-025 |
Recombinant Human CCL15/MIP-1 delta/LKN-1 (68 aa) (25 UG) |
25 UG |
R&D SYSTEMS |
| 628-LK-025/CF |
Recombinant Human CCL15/MIP-1 delta/LKN-1 (68 aa), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 629-LR-100 |
Recombinant Human Lymphotoxin beta R (LTbR)/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 630-TR-100 |
Recombinant Human TRAIL R3/TNFRSF10C/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 630-TR-100/CF |
Recombinant Human TRAIL R3/TNFRSF10C/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 631-T2-100 |
Recombinant Human TRAIL R2/TNFRSF10B/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 631-T2-100/CF |
Recombinant Human TRAIL R2/TNFRSF10B/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 633-TR-100 |
Recombinant Human TRAIL R4/TNFRSF10D/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 634-AG-100 |
Recombinant Mouse AgRP C-Terminal Fragment, CF |
100 µg |
R&D SYSTEMS |
| 634-AG-100 |
Recombinant Mouse AgRP C-Terminal Fragment, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 635-MS-025 |
Recombinant Human MSP beta Chain (25 UG) |
25 UG |
R&D SYSTEMS |
| 635-MS-025/CF |
Recombinant Human MSP beta Chain, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 636-AG-100 |
Recombinant Mouse AgRP C-Terminal Fragment, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 636-R1-025 |
Recombinant Human sTNF RI/TNFRSF1A (25 UG) |
25 UG |
R&D SYSTEMS |
| 636-R1-025/CF |
Recombinant Human Soluble TNF RI/TNFRSF1A, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 637-AR-100 |
Recombinant Human Activin RIA/ALK-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 638-A1-200 |
Recombinant Human EphA1/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 639-A2-200 |
Recombinant Mouse EphA2/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 640-A3-200 |
Recombinant Mouse EphA3/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 641-A4-200 |
Recombinant Mouse EphA4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 643-VM-050 |
Recombinant Mouse VCAM-1/CD106/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 643-VM-200 |
Recombinant Mouse VCAM-1/CD106/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 645-WN-010 |
Recombinant Mouse Wnt-5a (10 UG) |
10 UG |
R&D SYSTEMS |
| 645-WN-010/CF |
Recombinant Mouse Wnt-5a, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 648-EC-100 |
Recombinant Human E-Cadherin/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 649-EN-025 |
Recombinant Human CXCL5/ENA-70 (25 UG) |
25 UG |
R&D SYSTEMS |
| 649-EN-025/CF |
Recombinant Human CXCL5/ENA-70, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 650-T2-100 |
Recombinant Human TROP-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 651-NA-025 |
Recombinant Human CXCL5/ENA-74 (25 UG) |
25 UG |
R&D SYSTEMS |
| 651-NA-025/CF |
Recombinant Human CXCL5/ENA-74, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 652-P2-020 |
Recombinant Porcine IL-2 (20 UG) |
20 UG |
R&D SYSTEMS |
| 652-P2-020/CF |
Recombinant Porcine IL-2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 653-E3-025 |
Recombinant Human CCL26/Eotaxin-3 (25 UG) |
25 UG |
R&D SYSTEMS |
| 653-E3-025/CF |
Recombinant Human CCL26/Eotaxin-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 654-P4-025 |
Recombinant Porcine IL-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 654-P4-025/CF |
Recombinant Porcine IL-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 655-FR-050 |
Recombinant Human FGF R1 alpha (IIIb)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 656-AL-100 |
Recombinant Human ALCAM/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 658-FR-050 |
Recombinant Human FGF R1 alpha (IIIc)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 659-AB-005 |
Recombinant Human Activin B (5 UG) |
5 UG |
R&D SYSTEMS |
| 659-AB-005/CF |
Recombinant Human Activin B, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 659-AB-025 |
Recombinant Human Activin B (25 UG) |
25 UG |
R&D SYSTEMS |
| 659-AB-025/CF |
Recombinant Human Activin B, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 661-FR-050 |
Recombinant Human FGF R1 beta (IIIc)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 662-OR-100 |
Recombinant Mouse OSM R beta/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 663-FR-050 |
Recombinant Human FGF R2 alpha (IIIb)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 664-LI-025 |
Recombinant Human LIGHT/TNFSF14 (25 UG) |
25 UG |
R&D SYSTEMS |
| 664-LI-025/CF |
Recombinant Human LIGHT/TNFSF14, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 665-FR-050 |
Recombinant Human FGF R2 beta (IIIb)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 666-DN-050 |
Recombinant Human DNAM-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 669-FO-025 |
Recombinant Human Follistatin (25 UG) |
25 UG |
R&D SYSTEMS |
| 669-FO-025/CF |
Recombinant Human Follistatin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 670-FR-100 |
Recombinant Human GFR alpha-3/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 671-GP-100 |
Recombinant Human gp130/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 672-IT-025 |
Recombinant Human CXCL11/I-TAC (25 UG) |
25 UG |
R&D SYSTEMS |
| 672-IT-025/CF |
Recombinant Human CXCL11/I-TAC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 673-IR-100 |
Recombinant Human IFN-gamma R1 (100 UG) |
100 UG |
R&D SYSTEMS |
| 673-IR-100/CF |
Recombinant Human IFN-gamma R1, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 674-B2-025 |
Recombinant Human IGFBP-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 675-B3-025 |
Recombinant Human IGFBP-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 676-CP-100 |
Recombinant Human IL-1 R3/IL-1 R AcP/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 678-LY-010 |
Recombinant Human Lymphotoxin alpha1/beta2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 678-LY-010/CF |
Recombinant Human Lymphotoxin alpha1/beta2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 679-TX-010 |
Recombinant Human Lymphotoxin alpha2/beta1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 679-TX-010/CF |
Recombinant Human Lymphotoxin alpha2/beta1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 680-PI-010 |
Recombinant Porcine IL-1 alpha/IL-1F1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 680-PI-010/CF |
Recombinant Porcine IL-1 alpha/IL-1F1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 681-PI-010 |
Recombinant Porcine IL-1 beta/IL-1F2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 681-PI-010/CF |
Recombinant Porcine IL-1 beta/IL-1F2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 682-PL-050 |
Recombinant Human Prolactin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 683-RK-100 |
Recombinant Human RANK/TNFRSF11A/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 684-FR-050 |
Recombinant Human FGF R2 beta (IIIc)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 685-FR-050 |
Recombinant Human FGF R4/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 686-PI-025 |
Recombinant Porcine IL-6 (25 UG) |
25 UG |
R&D SYSTEMS |
| 686-PI-025/CF |
Recombinant Porcine IL-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 688-TK-100 |
Recombinant Human TrkB/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 689-GR-100 |
Recombinant Human GITR/TNFRSF18/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 690-PT-025 |
Recombinant Porcine TNF-alpha/TNFSF1A (25 UG) |
25 UG |
R&D SYSTEMS |
| 690-PT-025/CF |
Recombinant Porcine TNF-alpha/TNFSF2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 692-RK-100 |
Recombinant Mouse RANK/TNFRSF11A/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 693-PI-010 |
Recombinant Porcine IL-10 (10 UG) |
10 UG |
R&D SYSTEMS |
| 693-PI-010/CF |
Recombinant Porcine IL-10, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 694-GL-025 |
Recombinant Human GITR Ligand/TNFSF18 (25 UG) |
25 UG |
R&D SYSTEMS |
| R&D SYSTEMS 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
